Canaccord Genuity Maintains Buy on Hinge Health, Lowers Price Target to $53
Hinge Health, Inc. Class A +2.51%
Hinge Health, Inc. Class A HNGE | 38.78 | +2.51% |
Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:
HNGE) with a Buy and lowers the price target from $65 to $53.
